CRYOPORT, INC. Interest Payable
CRYOPORT, INC. (CYRX) had Interest Payable of $0 as of 2017-12-31, per its 10-K filed 2018-03-08.
Discontinued › Balance Sheet › Liabilities › Accrued Liabilities
us-gaap:InterestPayableCurrentAndNoncurrent · last filed 2018-03-08
- 2017-12-31: Interest Payable $0.00.
- 2017-09-30: Interest Payable $0.00.
- 2017-06-30: Interest Payable $0.00.
- 2017-03-31: Interest Payable $9.60K.
| Period end | Interest Payable | Interest Payable as first filed |
|---|---|---|
| 2017-12-31 | $0.00 10-K · filed 2018-03-08 | |
| 2017-09-30 | $0.00 10-Q · filed 2017-11-02 | |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $9.60K 10-Q · filed 2017-05-04 | |
| 2016-12-31 | $11.40K 10-K · filed 2018-03-08 | |
| 2016-09-30 | $13.00K 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $15.00K 10-Q · filed 2016-08-15 | |
| 2016-03-31 | $6.10K 10-KT · filed 2017-03-13 | |
| 2015-03-31 | $4.60K 10-K · filed 2016-06-28 | $24.00K 10-K · filed 2015-05-19 |
| 2014-12-31 | $24.00K 10-Q · filed 2015-02-05 | |
| 2014-09-30 | $24.00K 10-Q · filed 2014-11-12 | |
| 2014-06-30 | $24.00K 10-Q · filed 2014-07-31 | |
| 2013-03-31 | $9.92K 10-K · filed 2013-06-25 | |
| 2012-03-31 | $12.56K 10-K · filed 2013-06-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |